IMPACTING NEWS

AFFYMETRIX (AFFX)

THE SLAUGHTERING OF A GREAT COMPANY

We will wait until the hysterical selling stops and buy the stock of the company who has made the past of the biotech glory and will shape the future of the biotech industry, health care and medical practice. They took over $10 from the firm's $56 because the company has not met analysts' expectations today, for a quarter or one season and they know the reason for the lagging, while they overlooked estimating what would be this  firm's value one and two years in the future.  Anyway thanks for the opportunity given to those who have not had the chance to buy the stock of a unique biotech firm with unparalleled technology - the technology that will be the key to the development of the cures the world is dreaming about.

We continue to hold the stock and will accumulate on weaknesses whenever they come.

PROHOST RESEARCH P.O.BOX 640 429

Oakland Gardens, Ny 11364

Telephone : 516 678 1335

Fax 718 423 2731

E-mail prohost@aol.com

FORWARD-LOOKING STATEMENT Prohost is independent publication providing information on biotech companies. Prohost does not accept compensation from companies that are featured or profiled. It is strongly recommended that any purchase or sale decisions to any of the featured companies be discussed with a financial advisor or broker prior to completing any such purchase or sale decision. All statements or expressions are the opinion of Prohost and are not meant to be a solicitation or recommendation to buy, sell, or hold securities. Investing in embryonic companies, micro-cap and growth securities is highly speculative and carries a high degree of risk. It is possible that an investor can lose all of his/her investment in this type of companies that are profiled. The information that Prohost relies on is either through the profiled company, news services, research reports, interviews, or other outside sources that Prohost believes are reliable. Prohost makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure of the profiled companies and accepts no responsibilities for inaccuracies or misleading content in any material supplied by those clients. There can be no assurance that future events relating to the profiled company will occur as anticipated. The information contained herein is provided as an information service only. Past performance of featured companies does not guarantee the future success of any currently featured or profiled company. We encourage our readers to invest carefully and read the investor information provided by the Securities and Exchange Commission ("SEC") and/or the National Association of Securities Dealers ("NASD"). We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at: http://www.sec.gov/consumer/cyberfr.htm